What is Precision Medicine?
Faculty Disclosure Declaration Statement
This presenter has no conflict of interest or disclosure to declare of any financial interest or other relationship with any commercial entities discussed in this educational presentation.
This educational presentation was developed according to the planning, design, implementation and evaluation standards of the accreditation requirements for category 1 CME sponsors of the American Osteopathic Association (AOA). The Indiana Osteopathic Association (IOA) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy Statement
If you have any questions or concerns about this educational experience, you may call the IOA office at (317) 926-3009 or send an email message to email@example.com. All questions or concerns will be addressed promptly.
|Vigerust - Cardiovascular.pdf (4.00 MB)||Available after Purchase|
Dr. Vigerust received a bachelor’s degree in biology and chemistry from the University of Texas at El Paso, a master’s degree in microbiology and immunology from Texas Tech University in Lubbock, and a Ph.D. in cellular and molecular pathology from Vanderbilt University in Nashville, TN. Dr. Vigerust conducted post-doctoral research in the Department of Infectious Disease at St. Jude Children's Research Hospital in the areas of viral glycosylation, host defense from influenza, and bacterial secondary infection. Dr. Vigerust completed a second post-doctoral fellowship at Vanderbilt University Medical School in the Department of Pediatric Infectious Disease in the area of molecular biology of respiratory viruses. Dr. Vigerust was a faculty member in the Pathology, Immunology and Microbiology Department at Vanderbilt University School of Medicine and a Health Research Scientist in the U.S. Department of Veteran’s Affairs. Most recently, Dr. Vigerust was Chief Scientific Officer for a molecular diagnostics laboratory focused around prevention medicine. Dr. Vigerust has published extensively in international journals, presented his research at national and international conferences and is an active editor and reviewer for several journals. Dr. Vigerust has developed several novel molecular diagnostic essays for the prediction of cardiovascular risk in patients with diabetes, infectious disease and cancer. Over the past 20 years he has been the recipient of many awards for his research including the AAI Minority Scientist Award, ASCB MAC Junior Faculty Career Development Award, Keystone Symposia Early Career Investigator Award, Mirus Bio Research Award, NIAID Diversity Supplement Fellowship and the Elizabeth Glaser Pediatric AIDS Foundation Student Internship Award. In 2016 Dr. Vigerust was selected as a TEDx speaker on the subject of precision medicine. Dr. Vigerust currently maintains an adjunct assistant professor position at Vanderbilt University Medical Center in the Department of Neurological Surgery and a clinical assistant professor position with the University of Maryland, Eastern Shore School of Pharmacy. Dr. Vigerust’s academic and research interests focus around areas of precision medicine, diagnostics, infectious disease, traumatic brain injury, and neuroinflammation.
Dr. Vigerust discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Please wait ...